Home › Funds › Royce & Associates › PACS
Royce & Associates position in PACS
PACS GROUP INC · Health Care
Latest position (Q2 2026)912.49K sh
Reported value held$38.91M
Portfolio Weight0.31%
First reportedQ2 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 455.20K | $13.43M | New |
| Q3 2024 | 465.20K | $18.59M | Add |
| Q4 2024 | 918.42K | $12.04M | Add |
| Q1 2025 | 920.01K | $10.34M | Hold |
| Q2 2025 | 1.05M | $13.60M | Add |
| Q3 2025 | 1.86M | $25.53M | Add |
| Q4 2025 | 746.23K | $28.65M | Reduce |
| Q1 2026 | 907.72K | $29.16M | Add |
| Q2 2026 | 912.49K | $38.91M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PACS
- Fidelity Management & Research (FMR) 6.21M sh · $264.68M · Q2 2026
- BlackRock Inc 4.16M sh · $177.19M · Q2 2026
- Vanguard Group 4.51M sh · $172.99M · Q4 2025
- Geode Capital Management 1.21M sh · $51.55M · Q2 2026
- Morgan Stanley 750.75K sh · $32.01M · Q2 2026
- Citadel Advisors 724.64K sh · $30.90M · Q2 2026
- Wellington Management Group 664.86K sh · $28.35M · Q2 2026
- Goldman Sachs Group 452.90K sh · $19.31M · Q2 2026
- Northern Trust Corp 449.05K sh · $19.15M · Q2 2026
- Arrowstreet Capital 428.87K sh · $18.29M · Q2 2026
- Charles Schwab Investment Management 385.65K sh · $16.44M · Q2 2026